The biggest change is eating earlier in the evening. TD Cowen on semaglutide drugs: Significant uncertainty around what level of uptake will be achieved So how are analysts that have researched semaglutide (Ozempic, Wegovy, Rybelsus) or tirzepatide (Mounjaro, Zepbound) drugs thinking about their broader impact on the food industry
Understanding your FTO rs9939609 variant (linked to baseline appetite set-point) and MC4R rs17782313 variant (affecting hunger signaling) helps explain why you might lose weight faster or slower than someone on the same dose
By activating GLP-1 receptors, semaglutide helps: Stimulate insulin production when blood sugar is high Reduce glucagon secretion, which further lowers blood sugar Slow down digestion, promoting a feeling of fullness Decrease appetite by acting on brain centers controlling hunger The FDA has approved Ozempic for the treatment of type 2 diabetes, while Wegovy, a higher-dose formulation of semaglutide, is specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
Plus, appetite suppression isn't the only way semaglutide works as a weight loss drug
To set up a personal consultation where we can determine if you are a good candidate for one of these medications, please call our office at 303-839-7980 or fill out our contact form